Compass Pathways reports a Q2 loss of $17.5 million and announces raising $154.8 million in a new financing in May.

MindMed reports a Q2 2021 loss of $36 million. Current cash on hand of $157 million.

Wesana Health announces the commencement of pre-clinical psychedelics research for Traumatic Brain Injury.

The Mental Health Crisis is now a mental health pandemic. Is access to psychedelic medicine the world’s largest human rights issue?

ATAI’s newest research partner, Revixia Life Sciences, is seeking to treat depression and substance abuse with Salvinorin A, a lesser-known psychedelic used by indigenous peoples.

Marijuana reform has advanced in numerous state legislatures in the first half of 2021, with lawmakers enacting four new legalization laws so far this year.

Included in the $1.2 trillion infrastructure bill are provisions that would let researchers study cannabis from state-licensed dispensaries instead of the low-grade cannabis grown at government facilities.

Psychedelic drugs such as psilocybin and LSD can induce an experience known as oceanic boundlessness, which is characterized by a feeling of oneness with the world and a sense of awe. New research, published in the Journal of Psychopharmacology, provides some preliminary evidence that high doses of cannabis can also produce this type of altered state of consciousness.

Many places across the state recorded the rainiest July on record—that was great news for Kevyn Fowler. 

Two billion people have treatable mental health disorders. Where existing therapies are merely inadequate crutches, psychedelic drugs can produce cures.